OBJECTIVES: The purpose of this brief is to describe changes in the treated prevalence of medically managed attention-deficit/hyperactivity disorder (ADHD) among insured school-aged children and adolescents in the United States from 2009 to 2015. We examine the differences between those with employer-sponsored insurance (ESI) and with Medicaid insurance. METHODS: We utilized two large longitudinal administrative datasets containing medical and drug claims data on individuals with ESI and Medicaid insurance from Truven Health MarketScan® Administrative Claims Databases. Treated prevalence was measured as the percentage of school-aged children and adolescents enrolled in a calendar year who met the criteria for medically managed ADHD in the same calendar year. Subjects were eligible for inclusion if they were aged 6-17 years and were continuously enrolled during a calendar year. RESULTS: The annual prevalence of treated ADHD among school-aged children and adolescents with ESI increased from 4.5% in 2009 to 6.7% in 2015. Among those with Medicaid it increased from 11.3% in 2009 to 13.3% in 2012, and fell after 2012, remaining steady from 2013 through 2015. CONCLUSION: Treated prevalence of ADHD increased continuously over time among school-aged children and adolescents with ESI, but declined slightly after 2012 among those in the Medicaid sample.
OBJECTIVES: The purpose of this brief is to describe changes in the treated prevalence of medically managed attention-deficit/hyperactivity disorder (ADHD) among insured school-aged children and adolescents in the United States from 2009 to 2015. We examine the differences between those with employer-sponsored insurance (ESI) and with Medicaid insurance. METHODS: We utilized two large longitudinal administrative datasets containing medical and drug claims data on individuals with ESI and Medicaid insurance from Truven Health MarketScan® Administrative Claims Databases. Treated prevalence was measured as the percentage of school-aged children and adolescents enrolled in a calendar year who met the criteria for medically managed ADHD in the same calendar year. Subjects were eligible for inclusion if they were aged 6-17 years and were continuously enrolled during a calendar year. RESULTS: The annual prevalence of treated ADHD among school-aged children and adolescents with ESI increased from 4.5% in 2009 to 6.7% in 2015. Among those with Medicaid it increased from 11.3% in 2009 to 13.3% in 2012, and fell after 2012, remaining steady from 2013 through 2015. CONCLUSION: Treated prevalence of ADHD increased continuously over time among school-aged children and adolescents with ESI, but declined slightly after 2012 among those in the Medicaid sample.
Authors: Mark Wolraich; Lawrence Brown; Ronald T Brown; George DuPaul; Marian Earls; Heidi M Feldman; Theodore G Ganiats; Beth Kaplanek; Bruce Meyer; James Perrin; Karen Pierce; Michael Reiff; Martin T Stein; Susanna Visser Journal: Pediatrics Date: 2011-10-16 Impact factor: 7.124
Authors: Mark L Wolraich; Robert E McKeown; Susanna N Visser; David Bard; Steven Cuffe; Barbara Neas; Lorie L Geryk; Melissa Doffing; Matteo Bottai; Ann J Abramowitz; Laoma Beck; Joseph R Holbrook; Melissa Danielson Journal: J Atten Disord Date: 2012-09-05 Impact factor: 3.256
Authors: Coleen A Boyle; Sheree Boulet; Laura A Schieve; Robin A Cohen; Stephen J Blumberg; Marshalyn Yeargin-Allsopp; Susanna Visser; Michael D Kogan Journal: Pediatrics Date: 2011-05-23 Impact factor: 7.124
Authors: L Scahill; M Schwab-Stone; K R Merikangas; J F Leckman; H Zhang; S Kasl Journal: J Am Acad Child Adolesc Psychiatry Date: 1999-08 Impact factor: 8.829
Authors: Susanna N Visser; Melissa L Danielson; Rebecca H Bitsko; Joseph R Holbrook; Michael D Kogan; Reem M Ghandour; Ruth Perou; Stephen J Blumberg Journal: J Am Acad Child Adolesc Psychiatry Date: 2013-11-21 Impact factor: 8.829
Authors: Benjamin Zablotsky; Lindsey I Black; Matthew J Maenner; Laura A Schieve; Melissa L Danielson; Rebecca H Bitsko; Stephen J Blumberg; Michael D Kogan; Coleen A Boyle Journal: Pediatrics Date: 2019-10 Impact factor: 7.124
Authors: Melissa L Danielson; Rebecca H Bitsko; Reem M Ghandour; Joseph R Holbrook; Michael D Kogan; Stephen J Blumberg Journal: J Clin Child Adolesc Psychol Date: 2018-01-24
Authors: Melissa L Danielson; Rebecca H Bitsko; Joseph R Holbrook; Sana N Charania; Angelika H Claussen; Robert E McKeown; Steven P Cuffe; Julie Sarno Owens; Steven W Evans; Lorraine Kubicek; Kate Flory Journal: Child Psychiatry Hum Dev Date: 2021-06
Authors: Brian J Piper; Christy L Ogden; Olapeju M Simoyan; Daniel Y Chung; James F Caggiano; Stephanie D Nichols; Kenneth L McCall Journal: PLoS One Date: 2018-11-28 Impact factor: 3.240